Open Access<p>Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial</p>
Author(s) -
Steven Silverstein,
Elizabeth Yeu,
Joseph Tauber,
Michel Guillon,
Lyndon Jones,
David Galarreta,
Sruthi Srinivasan,
Venkiteshwar Manoj
Publication year - 2020
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s263362
Subject(s) - medicine , tolerability , artificial tears , confidence interval , cohort , ophthalmology , surgery , gastroenterology , adverse effect
To evaluate symptom relief in patients with dry eye disease (DED) following a single drop of propylene glycol-hydroxypropyl guar (PG-HPG) nanoemulsion (Systane ® Complete) lubricant eye drops.